Skip to content

A study comparing the effectiveness of homoeopathic medicines prepared by new and old method of potentization.

Clinical evaluation of preidentified homoeopathic medicines prepared by new vis- -vis old method of potentization in outpatient setting - A randomized trial - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102591
Enrollment
128
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R50-R69- General symptoms and signs

Interventions

Intervention1: Old method of potentization: Medicines will be selected based on the totality of symptoms and Homoeopathic principles. Available potencies are 6C, 30C, 200C, and 1M prepared by old meth

Sponsors

Central Council for research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18yrs to 60 years of both gender would be enrolled in the study. 2. Subjects presenting with symptomatic indications ascribed to the preidentified medicines. 3.Subjects who have not taken any medication for the past one week except on regular medication of Hypertension and Diabetes. 4.Subjects who have given the written informed consent.

Exclusion criteria

Exclusion criteria: 1.Subjects presenting with symptoms indicating prescription other than the preidentified medicines. 2. Subjects undergoing treatment (Ayurvedic, Homoeopathic, herbal, surgery etc.) which is likely to interfere in the course of this treatment. 3.Suffering from life-threatening disease/systemic illness (tuberculosis, cancer, AIDS, cardiovascular disorders etc.) 4. Pregnant/lactating women.

Design outcomes

Primary

MeasureTime frame
Modified Naranjo criteria to be assessed at the end of every month or /can be assessed earlier if the recovery is established with score more than or equal to 6.Timepoint: At the end of every month

Secondary

MeasureTime frame
Assessment of the patient using MYMOP scale at entry & Fortnightly. Assessment of the patient using ORIDL scale fortnightly. Assessment of the symptoms relieved during treatment by medicines prepared using new method & old method fortnightly. Timepoint: MYMOP- At Baseline & at every fortnight. ORIDL- At every fortnight

Countries

India

Contacts

Public ContactDr Pritha Mehra

Central Council for Research in Homoeopathy

dr.ritikanarula@gmail.com09811281206

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026